tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ALNY Stock Latest News

Alnylam price target raised to $479 from $395 at Wells Fargo
The FlyAlnylam price target raised to $479 from $395 at Wells Fargo
18d ago
ALNY
Alnylam announces results from post hoc analyses of HELIOS-B Phase 3 study
PremiumThe Fly
Alnylam announces results from post hoc analyses of HELIOS-B Phase 3 study
20d ago
ALNY
Alnylam removed from US Conviction List at Goldman Sachs
PremiumThe Fly
Alnylam removed from US Conviction List at Goldman Sachs
26d ago
ALNY
Alnylam Pharmaceuticals Reports Strong TTR Growth Amid Challenges
PremiumCompany Announcements
Alnylam Pharmaceuticals Reports Strong TTR Growth Amid Challenges
28d ago
ALNY
Alnylam Pharmaceuticals Launches Promising Phase 3 Study on Nucresiran for hATTR-PN
PremiumCompany Announcements
Alnylam Pharmaceuticals Launches Promising Phase 3 Study on Nucresiran for hATTR-PN
29d ago
ALNY
Alnylam price target raised to $500 from $490 at Oppenheimer
PremiumThe FlyAlnylam price target raised to $500 from $490 at Oppenheimer
29d ago
ALNY
Alnylam price target raised to $489 from $449 at Piper Sandler
Premium
The Fly
Alnylam price target raised to $489 from $449 at Piper Sandler
29d ago
ALNY
Alnylam price target raised to $527 from $460 at Barclays
Premium
The Fly
Alnylam price target raised to $527 from $460 at Barclays
29d ago
ALNY
Alnylam price target raised to $475 from $400 at Chardan
PremiumThe Fly
Alnylam price target raised to $475 from $400 at Chardan
29d ago
ALNY
Alnylam Pharmaceuticals Reports Strong Q3 2025 Growth
PremiumCompany Announcements
Alnylam Pharmaceuticals Reports Strong Q3 2025 Growth
29d ago
ALNY
Alnylam Pharma’s Strong Financial Performance and Strategic Growth Initiatives Justify Buy Rating
PremiumRatings
Alnylam Pharma’s Strong Financial Performance and Strategic Growth Initiatives Justify Buy Rating
29d ago
ALNY
Alnylam Pharma’s Strong Q3 Performance and Promising Outlook Reinforce Buy Rating Despite Legal Concerns
PremiumRatings
Alnylam Pharma’s Strong Q3 Performance and Promising Outlook Reinforce Buy Rating Despite Legal Concerns
30d ago
ALNY
Alnylam price target raised to $495 from $475 at Morgan Stanley
PremiumThe FlyAlnylam price target raised to $495 from $475 at Morgan Stanley
30d ago
ALNY
Alnylam price target lowered to $549 from $550 at Jefferies
Premium
The Fly
Alnylam price target lowered to $549 from $550 at Jefferies
30d ago
ALNY
Alnylam Pharma: Strong Sales Growth and Financial Performance Justify Buy Rating
Premium
Ratings
Alnylam Pharma: Strong Sales Growth and Financial Performance Justify Buy Rating
30d ago
ALNY
Alnylam reports Q3 EPS $1.84, consensus $1.75
PremiumThe Fly
Alnylam reports Q3 EPS $1.84, consensus $1.75
30d ago
ALNY
ALNY Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ALNY Upcoming Earnings Report: What to Expect?
1M ago
ALNY
Alnylam Pharmaceuticals: Strong Market Performance and Promising Pipeline Drive Buy Rating
PremiumRatings
Alnylam Pharmaceuticals: Strong Market Performance and Promising Pipeline Drive Buy Rating
1M ago
ALNY
Alnylam’s ZENITH Study: A New Horizon in Cardiovascular Treatment
PremiumCompany Announcements
Alnylam’s ZENITH Study: A New Horizon in Cardiovascular Treatment
1M ago
ALNY
Alnylam Pharmaceuticals Completes Phase 1 Study of ALN-TTRSC04: Market Implications
PremiumCompany AnnouncementsAlnylam Pharmaceuticals Completes Phase 1 Study of ALN-TTRSC04: Market Implications
1M ago
ALNY
Alnylam price target raised to $450 from $325 at Cantor Fitzgerald
Premium
The Fly
Alnylam price target raised to $450 from $325 at Cantor Fitzgerald
1M ago
ALNY
Alnylam price target raised to $535 from $459 at Truist
Premium
The Fly
Alnylam price target raised to $535 from $459 at Truist
1M ago
ALNY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >